anti-inflammatory
Biome Secures Purchase Order with NSLC & Delivers First Shipment
Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of recreational cannabis last year. After the landmark legislation, many licensed producers were caught off-guard by the high level of demand that quickly soaked up the available supply. These dynamics have created an opportunity for […]
FSD Pharma & Canntab Rank Among the Top 2018 Cannabis Stocks
The cannabis industry experienced significant growth last year, particularly in Canada following the legalization of adult-use cannabis on a federal level. The upcoming legalization of edible products across Canada could open the door to further growth in 2019 and beyond. Health Canada also continues to work through its backlog of licensed producer applicants to eliminate […]
Transcanna Holdings Inc. (CSE:TCAN) (“TransCanna” or the “Company”) is pleased to announce that TCM Distribution, Inc. (“TCMD”), the non-profit entity managed by the Company has received from the state of California its temporary distributor license. On December 31st TCMD submitted its permanent distribution license application to the state of California. On November 23rd, 2018 TCM Distribution, […]
Yield Growth Expands Innovative Topicals Line into Oregon
Oregon’s cannabis industry has experienced tremendous growth since adult-use legalization went into effect. According to New Frontier Data, the state will become the fifth largest market in the country with just over $1 billion in sales by 2020. With the growth in U.S. markets like these, many Canadian companies have leveraged their expertise gained in […]
City View Green Looks to Go Public with a Unique Approach to the Market
Canada’s cannabis industry is projected to exceed C$22.7 billion over the coming years, according to Deloitte, driven by the legalization of adult-use cannabis this year. With the legalization of edibles and other consumer products next year, the industry could see even faster growth as a greater number of consumers become interested. Investors seeking exposure may […]
Company: Lexaria Bioscience Corp. (LXRP) Category: Stock Spotlights January 8, 2019 Biotechnology company Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) revolutionary technology, DehydraTECH, alters the way that fat soluble, plant-derived molecules are absorbed into the body. A recent article further discussing the company reads, “Chemicals or intimidating complex ingredients that require disclosure on food labels are […]
Pascal Biosciences Provides Year-End Investor Update and Reviews Upcoming Milestones
– 2018 pipeline expansion includes lead cannabinoid-based cancer therapeutic – Clinical trial in glioblastoma to begin in 2019 VANCOUVER, British Columbia and SEATTLE, Dec. 20, 2018 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced a year-end review of accomplishments during 2018 and insight into plans […]
Wiz Khalifa Partners with Supreme to Expand Cannabis Brand
The music industry has become increasingly intertwined with the cannabis industry over the past several years. With the partnership between Canopy Growth Corp. (TSX: WEED) (NYSE: CGC) and Snoop Dogg in 2016, these relationships grew even closer on an international level. Cannabis companies around the world have sought out ways to partner with these musicians […]
NanoSphere Closes $1.335M First Tranche of Private Placement
DENVER–(BUSINESS WIRE)–NanoSphere Health Sciences Inc. (CSE: NSHS) (OTC: NSHSF) the biotechnology leader behind the patented NanoSphere Delivery System™, is pleased to announce a first tranche closing of its non-brokered private placement announced November 28, 2018. Pursuant to the first tranche, the company issued 4,452,254 Units at a price of $0.30 per Unit for gross proceeds […]
NexTech Looks to Bring Augmented Reality to Ecommerce
Ecommerce spending is projected to rise from $2.3 trillion in 2017 to $4.5 trillion by 2021, according to Statista, as consumers transition from brick-and-mortar to online shopping. While desktops still represent about 60 percent of the market, mobile ecommerce users have grown to capture about 40 percent of the market. New technologies, like augmented reality, […]
Creso Pharma: A Truly Global Cannabis Company
The North American cannabis industry is littered with companies touting global ambitions. There are regular announcements regarding letters of intent to distribute in emerging markets like Europe and Latin America, long on potential and short on concrete details. Many of these announcements are speculative at best, requiring a mix of regulatory approvals, licensing, product development, […]
AREV Builds an Industry-Leading Cannabis Topicals Portfolio
The global skincare and dermatology market is projected to grow from $20 billion in 2015 to $33.7 billion by 2022, according to GBI Research, representing a 7.73 percent compound annual growth rate. While premium biologics have become a popular treatment category, the legalization of cannabis has opened the door to the benefits of cannabinoids and […]
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
The producers of O’ Cannabiz have decades of experience producing national-profile events and creating global connections between business communities in the arts, broadcasting, media and technology. They have organized trade summit initiatives with governments around the world. And they have worked closely with sponsors in all levels of Canadian government.
Tom Zuber is Zuber Lawler & Del Duca’s Managing Partner. He has a degree with highest honors in biomedical engineering and has advised some of the most iconic companies in the world on their patent and trademark portfolios. He is at the cutting edge of cannabis patent and trademark law. He holds degrees from Harvard University and Columbia Law […]
Gage Cannabis Co. is innovating and curating the highest quality cannabis experiences possible for cannabis consumers in the state of Michigan and bringing internationally renowned brands to market.
JWC is a Licensed Producer under the ACMPR with the goal of helping patients by providing clean, consistent medical cannabis products.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
